Tranexamic Acid Reduces Blood Loss in Off-Pump Coronary Artery Bypass Surgery

ObjectiveThis study was designed to evaluate the hemostatic effect of tranexamic acid in off-pump coronary artery bypass surgery.DesignA prospective, randomized, double-blind, placebo-controlled study.SettingThe Department of Anesthesiology and Cardiac Surgery, Medical Sciences University.ParticipantsOne hundred eight patients undergoing off-pump coronary artery bypass surgery were enrolled into the study. Eight patients were withdrawn, and 100 patients were divided into 2 groups.InterventionsFifty patients received tranexamic acid (bolus 1 g before skin incision and followed by maintenance dose of 400 mg/h during surgery), and 50 patients received saline.Measurement and Main ResultsHematologic parameters, volume of blood loss, blood transfusion, and other clinical data were recorded throughout the perioperative period. Twenty-four-hour postoperative blood loss was significantly less in the tranexamic acid group compared with the control group (471 ± 182 v 844 ± 303). Patients in the tranexamic acid group received significantly less allogeneic blood (8 v 31 units).ConclusionBleeding and hemorrhagic complications and the consequent need for allogeneic transfusion are still major problems after off-pump coronary artery bypass surgery. Tranexamic acid appears to be effective in reducing postoperative bleeding and the need for allogeneic blood products.